Fig. 4From: 3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioinkImmunocytochemistry analysis of HN1 and AD bioprinted constructs on day 30 of culture. Successful generation of BFCN models are indicated by the cholinergic marker ChAT and neuronal marker Tuj1. Scale bar is 20 µmBack to article page